Literature DB >> 8016895

Muscarinic acetylcholine receptor subtypes in smooth muscle.

R M Eglen1, H Reddy, N Watson, R A Challiss.   

Abstract

Muscarinic acetylcholine M2 and M3 receptor subtypes are coexpressed in many types of smooth muscle including gastrointestinal smooth muscle, urinary bladder and vascular and airway tissue. Activation of M3 receptors, via the G protein Gq, results in increased polyphosphoinositide hydrolysis, release of Ca2+ ions from the sarcoplasmic reticulum and consequently causes contraction. Quantitation of the relative expression of M2 and M3 receptors has shown that the proportion of M2 receptors often predominates over the M3 receptor population by 4:1 or more. Although it is established that M2 receptors preferentially link, via a pertussis-toxin-sensitive G protein Gi, to inhibition of adenylate cyclase activity, relatively little is known concerning the physiological role of the M2 receptor population. In this review, Richard Eglen and colleagues discuss recent data concerning the possible role(s) of muscarinic receptor subtypes in smooth muscle and appraise the pharmacological methods for dissecting the function of muscarinic receptor subtypes in tissues co-expressing multiple receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016895     DOI: 10.1016/0165-6147(94)90047-7

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  34 in total

1.  Receptor binding studies of soft anticholinergic agents.

Authors:  F Huang; P Buchwald; C E Browne; H H Farag; W M Wu; F Ji; G Hochhaus; N Bodor
Journal:  AAPS PharmSci       Date:  2001

2.  The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro.

Authors:  T Yamanishi; C R Chapple; K Yasuda; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Indirect muscarinic receptor activation by pentamidine on airway smooth muscle.

Authors:  K Biyah; M Molimard; E Naline; B Bazelly; C Advenier
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Mutations in a C. elegans Gqalpha gene disrupt movement, egg laying, and viability.

Authors:  L Brundage; L Avery; A Katz; U J Kim; J E Mendel; P W Sternberg; M I Simon
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

5.  Expression and localization of muscarinic receptors in P19-derived neurons.

Authors:  D Parnas; E Heldman; L Branski; N Feinstein; M Linial
Journal:  J Mol Neurosci       Date:  1998-02       Impact factor: 3.444

6.  M1 and M3 muscarinic receptors in human pulmonary arteries.

Authors:  X Norel; L Walch; M Costantino; C Labat; I Gorenne; E Dulmet; F Rossi; C Brink
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle.

Authors:  Alexandra Wibberley; Zunxuan Chen; Erding Hu; J Paul Hieble; Timothy D Westfall
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.

Authors:  Tomomi Oki; Shuichi Sato; Keiji Miyata; Shizuo Yamada
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

9.  Muscarinic receptors in the prenatal mouse embryo. Comparison of M35-immunohistochemistry with [3H]quinuclidinyl benzylate autoradiography.

Authors:  M Lammerding-Köppel; A Greiner-Schröder; U Drews
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

10.  G-protein involvement in muscarinic receptor-stimulation of inositol phosphates in longitudinal smooth muscle from the small intestine of the guinea-pig.

Authors:  S A Prestwich; T B Bolton
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.